The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number:3235-0006
Expires:Oct 31, 2018
Estimated average burden
hours per response:23.8

COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
AGILE THERAPEUTICS INCCOM00847L10018,9402,171,831SH SOLE 2,171,83100
AMBIT BIOSCIENCES CORPCOM02318X10011,4001,650,156SH SOLE 1,650,15600
CEMPRA INCCOM15130J10935,3303,293,060SH SOLE 3,293,06000
CEMPRA INCCOM15130J10942940,000SHCallSOLE 000
CHIMERIX INCCOM16934W10633,4101,522,943SH SOLE 1,522,94300
DURATA THERAPEUTICS INCCOM26658A10734,5702,030,175SH SOLE 2,030,17500
ESPERION THERAPEUTICS INC NECOM29664W10532,5402,054,594SH SOLE 2,054,59400
LOMBARD MED INCCOMG555981096,380886,363SH SOLE 886,36300
MEI PHARMA INCCOM NEW55279B2024,880770,000SH SOLE 770,00000
PERNIX THERAPEUTICS HLDGS INCOM71426V10818,0502,010,000SH SOLE 2,010,00000
PERNIX THERAPEUTICS HLDGS INCOM71426V1089010,000SHCallSOLE 000
SORRENTO THERAPEUTICS INCCOM NEW83587F20211,9001,763,500SH SOLE 1,763,50000
TRANSENTERIX INCCOM NEW89366M20142,0108,335,819SH SOLE 8,335,81900
VERSARTIS INCCOM92529L10255,0901,964,568SH SOLE 1,964,56800
ZELTIQ AESTHETICS INCCOM98933Q10839,4602,597,742SH SOLE 2,597,74200
ZELTIQ AESTHETICS INCCOM98933Q10865743,261SHCallSOLE 000